JPRN-UMIN000001859已完成未知
Invention of new strategy against endstage ischemic heart failure using left ventricular assist device and autologous cell transplantation - Invention of new strategy against endstage ischemic heart failure using left ventricular assist device and autologous cell transplantation
Osaka University, Graduate School of Medicine, Division of Crdiovascular Surgery, Department of Surgery0 个研究点目标入组 6 人开始时间: 2009年4月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The major exclusion criteria consists of peripheral muscular dystrophy, malignancies, pregnancy, alcoholic, and positive serologic test results for human immunodeficient virus, hepatitis, human T lymphotrophic virus type 1 and syphilis.
研究者
相似试验
已完成
不适用
Development of new strategy for severe heart failure using aoutologous myoblast sheets.ischaemic cardiomyopathy, dilated cardiomyopathyJPRN-UMIN000003273Osaka University Graduate school of medicine, Cardiovascular surgery16
进行中（未招募）
1 期
Combined drug approach to prevent liver injury during transplantation.Investigation of the ischemia-reperfusion injury in patients who will undergo a liver transplantation after receiving a drug combination/multifactorial modulationEUCTR2012-001960-31-BEZ Leuven82
进行中（未招募）
1 期
Postconditioning used for the limitation of infarct size in patients with ST-elevation myocardial infarction (POSTCON). - POSTCOPatients with ST-segment elevation myocardial infarction (STEMI) are routinely treated with primary PCI (pPCI) as a world wide standard. Glucagon like peptide (GLP1) is a genuine hormone created in the gut and with well characterized receptors in heart muscle. Previous studies have proven it to be safe in human and intravenous administration for 72 hours have shown it to reduce infarct size in pPCI.EUCTR2007-001221-10-DKRigshospitalet, University of Copenhagen200
招募中
不适用
comparison of cilostazol and aspirin in acute ischemic patients with high-risk of cerebral hemorrhageDiseases of the nervous systemKCT0000355Asan Medical Center1,600
进行中（未招募）
不适用
A new therapeutic approach to prevent acute complications in type 2 diabetes: The effect of the combination of the GLP-1 Analog Liraglutide and Insulin LEvemir® against the cOnventional insulin therapy: GALILEOdiabetes mellitus type 2, inadequate metabolic control, indication for insulin therapymyocardial lipid accumulation and left-ventricular function, retinal changes, microabluminuria, beta-cell-function, endothelial dysfunctionMedDRA version: 14.1Level: PTClassification code 10012607Term: Diabetes mellitus inadequate controlSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 14.1Level: PTClassification code 10012689Term: Diabetic retinopathySystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 14.1Level: HLTClassification code 10012654Term: Diabetic complications cardiovascularSystem Organ Class: 10014698 - Endocrine disordersMedDRA version: 14.1Level: PTClassification code 10012647Term: Diabetic cardiomyopathySystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 14.1Level: HLTClassification code 10012658Term: Diabetic complications renalSystem Organ Class: 10014698 - Endocrine disordersMedDRA version: 14.1Level: HLTClassification code 10012657Term: Diabetic complications ophthalmicSystem Organ Class: 10014698 - Endocrine disordersMedDRA version: 14.1Level: PTClassification code 10054044Term: Diabetic microangiopathySystem Organ Class: 10047065 - Vascular disordersMedDRA version: 14.1Level: HLGTClassification code 10012653Term: Diabetic complicationsSystem Organ Class: 10014698 - Endocrine disordersEUCTR2012-001208-39-ATMedizinische Universität Wien, Univ.Klinik für Innere Medizin III, Abt.f.Endokrinologie und Stoffwechsel